Cost-Effectiveness of a Smoking Cessation Program Implemented at the Time of Surgery for Lung Cancer

Background: Many patients are active smokers at the time of a diagnosis of surgically resectable lung cancer. Perioperative smoking cessation is associated with improved survival, but the cost-effectiveness of a smoking cessation program initiated immediately before surgery is unknown. Methods: We developed a decision analytic Markov model to evaluate the incremental cost-effectiveness of a formal smoking cessation program. The parameter estimates were taken from the available literature. The model included the cost and effectiveness of the smoking cessation program, cost and incidence of perioperative complications, postoperative mortality, and utility measured in quality adjusted life years (QALY). Dollars per QALY and life year were calculated and one-way sensitivity analyses were performed. Results: The cost/QALY and cost/life year were $16,415 and $45,629 at 1 year after surgery and $2609 and $2703 at 5 years, respectively. Most sensitivity analyses showed the 1 year postsurgery cost/QALY estimates were less than $50,000, and all were less than $12,000 at 5 years. Cost-effectiveness estimates were most sensitive to the frequency of perioperative complications and the estimated short-term utility estimates. Conclusion: A smoking cessation program initiated before surgical lung resection is cost-effective at both 1 and 5 years postsurgery. Providers should encourage patients who are still smoking to engage in formal smoking cessation programs.

[1]  Changli Wang,et al.  Influence of smoking on histologic type and the efficacy of adjuvant chemotherapy in resected non-small cell lung cancer. , 2008, Lung cancer.

[2]  John P Griffin,et al.  Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). , 2007, Chest.

[3]  MSc Douglas K. Owens MD,et al.  Interpretation of cost-effectiveness analyses , 2007, Journal of General Internal Medicine.

[4]  C. Pohlig.  Smoking cessation counseling: a practice management perspective. , 2006, Chest.

[5]  A. Theadom,et al.  Effects of preoperative smoking cessation on the incidence and risk of intraoperative and postoperative complications in adult smokers: a systematic review , 2006, Tobacco Control.

[6]  D. Neuberg,et al.  Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients. , 2006, Lung cancer.

[7]  G. Byrnes,et al.  Validity of the Assessment of Quality of Life (AQoL) utility instrument in patients with operable and inoperable lung cancer. , 2006, Lung cancer.

[8]  C. Jaén,et al.  An update on tobacco cessation reimbursement. , 2006, Family practice management.

[9]  D. Vidrine,et al.  Successes and failures of the teachable moment , 2006, Cancer.

[10]  T. Thomsen,et al.  Interventions for preoperative smoking cessation. , 2014, The Cochrane database of systematic reviews.

[11]  J. Cornuz,et al.  Biomedical risk assessment as an aid for smoking cessation. , 2012, The Cochrane database of systematic reviews.

[12]  N. Altorki,et al.  Cost effectiveness of chest computed tomography after lung cancer resection: a decision analysis model. , 2005, The Annals of thoracic surgery.

[13]  Merete Osler,et al.  Effect of smoking reduction on lung cancer risk. , 2005, JAMA.

[14]  M. Bains,et al.  Smoking and timing of cessation: impact on pulmonary complications after thoracotomy. , 2005, Chest.

[15]  C. Patten,et al.  Nicotine dependence treatment: perceived health status improvement with 1-year continuous smoking abstinence. , 2005, European journal of public health.

[16]  N. Anthonisen,et al.  The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial , 2005 .

[17]  E. van Marck,et al.  Prognostic value of smoking status in operated non-small cell lung cancer. , 2005, Lung cancer.

[18]  C. Rissel,et al.  A programme for reducing smoking in pre‐operative surgical patients: randomised controlled trial * , 2005, Anaesthesia.

[19]  J. Sloan,et al.  The relationship between cigarette smoking and quality of life after lung cancer diagnosis. , 2004, Chest.

[20]  Joy L. Johnson,et al.  Efficacy of a smoking-cessation intervention for elective-surgical patients. , 2004, Research in nursing & health.

[21]  Office on Smoking.  The Health Consequences of Smoking: A Report of the Surgeon General , 2004 .

[22]  P. Kvale,et al.  Smoking and lung cancer survival: the role of comorbidity and treatment. , 2004, Chest.

[23]  T. Jørgensen,et al.  Short‐term pre‐operative smoking cessation intervention does not affect postoperative complications in colorectal surgery: a randomized clinical trial , 2003, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[24]  W. Koh,et al.  Survival among Chinese women with lung cancer in Singapore: a comparison by stage, histology and smoking status. , 2003, Lung cancer.

[25]  M. Rué,et al.  Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the Eastern Cooperative Oncology Group. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  M. Clark,et al.  Tobacco use outcomes among patients with lung cancer treated for nicotine dependence. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  A. Møller,et al.  Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial , 2002, The Lancet.

[28]  R. Hays,et al.  Responsiveness of the Smoking Cessation Quality of Life (SCQoL) questionnaire. , 2001, Clinical therapeutics.

[29]  Richard Doll,et al.  Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies , 2000, BMJ : British Medical Journal.

[30]  K. Hiroshima,et al.  Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  M. Ferguson,et al.  Assessment of pulmonary complications after lung resection. , 1999, The Annals of thoracic surgery.

[32]  V. Hasselblad,et al.  Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. , 1997, JAMA.

[33]  J. Cooper,et al.  Smoking cessation and lung cancer resection. , 1996, Chest.

[34]  A S Detsky,et al.  How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[35]  K. Offord,et al.  Role of preoperative cessation of smoking and other factors in postoperative pulmonary complications: a blinded prospective study of coronary artery bypass patients. , 1989, Mayo Clinic proceedings.